New 2025 data reveals that consumer interest in dermal filler treatments across the UK is accelerating, with Millennials leading the charge.
Commissioned by hyaluronic acid filler brand Teoxane and conducted by research agency Norstat, the study surveyed 2,500 women aged 18-55 in the UK.
It found that over half of dermal filler users are now under the age of 35, with those aged 26-34 accounting for more than 75% of that cohort.
This shift points to a rising preference for non-surgical aesthetic treatments that are quick, effective and involve minimal downtime.
With the UK dermal fillers market projected to grow from $0.44 billion in 2024 to $2.06 billion by 2035, aesthetic professionals are advised to stay ahead of changing patient expectations and treatment trends.
Millennials and preventative aesthetic treatments are leading the market
Millennials – typically in their late 30s and early 40s – are now among the highest spenders on dermal fillers, according to Dr Saleena Zimri.
This generation, often balancing family life and professional careers, is opting for preventative aesthetic procedures to address early signs of ageing such as fine lines and volume loss.
Younger Gen Z patients, while cost-conscious, are showing growing interest in aesthetic treatments, particularly those targeting lips and skin texture.
The demand is highest in metropolitan and trend-influencing regions such as London and the North of England, including cities like Manchester.
Demand for mid-face fillers and GLP-1-related treatments on the rise
A key trend in 2025 is the increased popularity of mid-face dermal fillers, which offer high-impact rejuvenation results.
Dr Wassim Taktouk highlights a spike in patients using GLP-1 medications (like semaglutide) seeking fillers to combat facial volume loss caused by these treatments.
Redensity 1 remains a go-to for enhancing skin quality in younger patients, while older demographics are opting for more comprehensive rejuvenation across multiple areas, particularly as post-menopausal interest in aesthetic maintenance grows.
The role of social media and confidence in treatment uptake
While boosting self-confidence remains the top driver behind dermal filler treatments, Teoxane’s findings also indicate a rise in secondary motivations such as looking good on social media and being influenced by celebrities discussing their treatments openly.
Dr Bonny Armstrong explains that social media has helped normalise injectables, but warns of the negative impact of filters and unrealistic beauty ideals.
For many patients, enhancing their appearance is part of a wider self-care routine linked to wellbeing, mental health and even career success in the digital age.
What aesthetic professionals should know in 2025
As the UK dermal filler market continues to expand, aesthetic practitioners are encouraged to stay educated on emerging trends:
- Mid-face treatments are in high demand, particularly among GLP-1 users and patients aged 26-34.
- Lip fillers remain the number one treatment indication in the UK.
- Preventative and skin-quality-focused treatments are increasingly sought after by younger patients.
- Confidence, wellness and digital presence are key motivators across all age groups.
- Transparency and ethical communication around aesthetic outcomes are more important than ever.
With evolving patient behaviour and rising expectations, practitioners must combine advanced clinical knowledge with an understanding of today’s digitally influenced, wellness-driven aesthetic patient.
